Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure enables selective binding in neuroreceptor modulation, making it valuable in creating anxiolytic and anticonvulsant drugs. The compound's bromo and triazolopyridine moieties allow for further functionalization through cross-coupling reactions, facilitating the production of diverse analogs for drug discovery. It is also employed in radiolabeling studies when combined with isotopic lithium, supporting metabolic and distribution analysis in preclinical research.